AAAAAA

   
Results: 1-8 |
Results: 8
Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program
Authors: Bos, JM Rumke, HC Welte, R Postma, MJ Jager, JC
Citation: Jm. Bos et al., Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program, VACCINE, 20(1-2), 2001, pp. 202-207
Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors
Authors: Van Loveren, H Van Amsterdam, JGC Vandebriel, RJ Kimman, TG Rumke, HC Steerenberg, PS Vos, JG
Citation: H. Van Loveren et al., Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors, ENVIR H PER, 109(8), 2001, pp. 757-764
Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands
Authors: Oostvogel, PM Rumke, HC Conyn-van Spaendonck, MAE van der Avoort, HGAM Leeuwenburg, J van Loon, AM
Citation: Pm. Oostvogel et al., Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands, J INFEC DIS, 184(11), 2001, pp. 1451-1455
Prevention of meningococcal serogroup B infections in children: A protein-based vaccine induces immunologic memory
Authors: de Kleijn, ED de Groot, R Lafeber, AB Labadie, J van Limpt, CJP Visser, J Berbers, GAM van Alphen, L Rumke, HC
Citation: Ed. De Kleijn et al., Prevention of meningococcal serogroup B infections in children: A protein-based vaccine induces immunologic memory, J INFEC DIS, 184(1), 2001, pp. 98-102
Reemergence of pertussis in the highly vaccinated population of the Netherlands: Observations on surveillance data
Authors: de Melker, HE Schellekens, JFP Neppelenbroek, SE Mooi, FR Rumke, HC Conyn-van Spaendonck, MAE
Citation: He. De Melker et al., Reemergence of pertussis in the highly vaccinated population of the Netherlands: Observations on surveillance data, EM INFECT D, 6(4), 2000, pp. 348-357
Immunogenicity and safety of monovalent P1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations
Authors: de Kleijn, ED de Groot, R Lafeber, AB Labadie, J van Limpt, KCJP Visser, J Berbers, GAM van Alphen, L Rumke, HC
Citation: Ed. De Kleijn et al., Immunogenicity and safety of monovalent P1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations, VACCINE, 19(9-10), 2000, pp. 1141-1148
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age
Authors: de Kleijn, ED de Groot, R Labadie, J Lafeber, AB van den Dobbelsteen, G van Alphen, L van Dijken, H Kuipers, B van Omme, GW Wala, M Juttmann, R Rumke, HC
Citation: Ed. De Kleijn et al., Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age, VACCINE, 18(15), 2000, pp. 1456-1466
A population-based study on tetanus antitoxin levels in the Netherlands
Authors: de Melker, HE van den Hof, S Berbers, GAM Nagelkerke, NJD Rumke, HC Conyn-van Spaendonck, MAE
Citation: He. De Melker et al., A population-based study on tetanus antitoxin levels in the Netherlands, VACCINE, 18(1-2), 1999, pp. 100-108
Risultati: 1-8 |